Janoshik · PRIMARY REPORT
View COA ↗BPC-157 / TB-500 blend — report 213565
Batch: CP012606261920L · BB20
Reference only: BPC-157 / TB-500 (889 Da), not BPC-157 / Ac-SDKP. This does not certify the current Wolvera formulation.
Product visualization · Label shown for illustration; your selected dose is recorded in the inquiry.
PHARMACEUTICAL-GRADE RESEARCH MATERIALS
Wolvera
BPC-157 + Ac-SDKP
Wolvera combines BPC-157 with Ac-SDKP as a more advanced alternative to conventional TB-500-based recovery blends.
For laboratory research only. Not for human or veterinary use.
Local delivery in Chiang Mai. Contact us to confirm timing and charges.
Wolvera10 mg
BPC-157 + Ac-SDKP
Tissue repair
Fibrosis pathways
Wolvera
Overview
Wolvera combines BPC-157 with Ac-SDKP as a more advanced alternative to conventional TB-500-based recovery blends. Available in 10 mg and 20 mg doses, the blend brings together two areas of experimental research: tissue repair and control of excessive scar-tissue formation. Ac-SDKP is a four-amino-acid fragment derived from thymosin beta-4, with anti-inflammatory and antifibrotic effects demonstrated in animal models.
How it works
BPC-157 and Ac-SDKP bring tissue repair and control of excessive scar-tissue formation into one blend. Ac-SDKP is a four-amino-acid fragment derived from thymosin beta-4.
Compound details
- Compound identity
- BPC-157 + Ac-SDKP
- Compound class
- Two-peptide blend
- Target / pathway
- Tissue repair · Fibrosis pathways
- Presentation
- Lyophilized powder
- Vial capacity
- 3 mL
Preparation & storage
Check the selected dose before calculating a solution concentration. Use the diluent and storage conditions specified for the material. Record the preparation date, concentration and storage conditions on the vial; the guides below explain preparation, measurement and storage terminology.
ANALYTICAL DOCUMENTATION
Certificates of analysis.
Janoshik reports are listed first. Results apply to the tested sample and batch; ask us to match the report to the batch proposed for your inquiry.
Freedom Diagnostics
View COA ↗BPC-157 / TB-500 10 mg — August 2026
Batch: Not stated in supplied copy · BPC-157 / TB-500 10 mg
Reference only: BPC-157 / TB-500, not BPC-157 / Ac-SDKP. Client and batch are not stated; this does not certify the current Wolvera formulation.
Freedom Diagnostics
View COA ↗Wolverine 20 mg — May 2026
Batch: 001 · Ac-SDKP / BPC-157
Other supplier reference: Lioness Labs, Ac-SDKP / BPC-157, 20 mg. This report does not certify a LotusLabs Wolvera 10 mg or 20 mg batch.
Product FAQs
What is the compound?
BPC-157 + Ac-SDKP. Two-peptide blend.
What does the selected dose mean?
The selector shows the total amount supplied per vial. Quantity is the number of vials requested.
Where are the preparation references?
The preparation and storage section links to guides on reconstitution, storage and measurement. Compound background references are listed under Sources.